ArticleFrontiers in medicine2026
Endoscopic ultrasound-guided cyanoacrylate therapy for gastric variceal bleeding secondary to sinistral portal hypertension: a retrospective case series.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To describe the feasibility and outcomes of endoscopic ultrasound (EUS) in the treatment of gastric variceal bleeding secondary to sinistral portal hypertension (SPH). Methods: A retrospective analysis was performed on patients with gastric variceal bleeding secondary to SPH who received EUS-guided treatment at Beijing Ditan Hospital, Capital Medical University from January 2021 to May 2025. Clinical data of the enrolled patients were retrospectively reviewed to evaluate the therapeutic effect of EUS-guided intervention for gastric varices (GVs), including variceal obliteration and recurrence, as well as early and late rebleeding events. Results: A total of four patients with SPH complicated with gastric variceal bleeding underwent EUS-guided treatment, including two males and two females, with a mean age of 35.8 years. The underlying cause was splenic vein occlusion, which was secondary to chronic pancreatitis in three patients and to a pancreatic mass in one patient. Surveillance endoscopy and contrast-enhanced computed tomography (CECT) performed at 3 months after treatment showed substantial reduction of gastric fundal varices in three patients, who subsequently completed telephone follow-up at 6 months and 1 year. No rebleeding occurred in these three patients. One female patient declined surveillance gastroscopy. 1 year post-procedure, she developed recurrent gastric variceal bleeding during the second trimester (15 weeks of gestation). No further bleeding was observed after endoscopic hemostasis. She underwent splenectomy half a year following uneventful delivery. Conclusion: EUS-guided therapy appears feasible for the management of gastric variceal bleeding secondary to SPH, particularly in patients with poor general status who are intolerant to or decline surgical treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.